Top States: CA | DC | FL | GA | MA | NC | NJ | NY | OH | TX | WA |

Thermal Angel Blood Warmer Company Recruits Former Air Force Surgeon General to Sit on Medical Advisory Board

By :: Wed, 13 Oct 2010 01:59:58 -0400 EDT

Paul K Carlton JrDALLAS, Texas, Oct. 13 (SEND2PRESS NEWSWIRE) — Estill Medical Technologies, Inc., the creator of the Thermal Angel Blood Warmer, announced this week that Paul K. Carlton, Jr., M.D., Lt. General, USAF (Ret) has joined its advisory board.

The Thermal Angel Blood and IV Fluid Infusion Warmer is a patented medical device that is being used by U.S. hospitals and military and emergency responders around the globe to lessen the effects of fluid-induced hypothermia.

“We are very excited to welcome Lt. General Carlton to the Board of Advisors,” says Jay Lopez, president and CEO for Estill Medical Technologies, Inc. “We are confident that he will be a valuable asset in many areas, including new product development for specific military medical needs.”

About Paul K. Carlton, Jr., M.D., Lt. General, USAF (Ret):
Dr. Paul K. Carlton, Jr. has a B.S. from the U.S. Air Force Academy and a doctorate of medicine from the University of Colorado. He currently serves as Director to the Office of Innovations and Preparedness for The Texas A&M University System Health Science Center. Prior to this, he was the Air Force Surgeon General from 1999 to 2002.

As the Surgeon General, he served as a functional manager of the U.S. Air Force Medical Service. He had authority to commit resources, worldwide; to make decisions affecting the delivery of medical services; and to develop plans, programs and procedures to support peacetime and wartime medical service missions.

His vision for medical care in the combat zone led directly to the nation’s current best survival rate in the history of warfare.

About Estill Medical Technologies, Inc.:
Estill Medical Technologies’ Thermal Angel Blood and IV Fluid Infusion Warmer was recently named, “2010 Outstanding Military Product of the Year,” by the Institute for Defense and Government Advancement.

The Thermal Angel uses advanced technology which regulates the temperature of blood or IV fluid almost 5,000 times per second. It requires only 30 seconds to set up and to start delivering warm fluid. It’s also disposable and lightweight (only nine ounces).

“We continue to work on new products with innovative technology that can be adapted to any health care environment,” adds Lopez.

For more details, visit: www.thermalangel.com.

News Source: Estill Medical Technologies, Inc. :: This press release was issued on behalf of the news source by Send2Press® Newswire, a service of Neotrope®.

» Plain text copy of press release (and media contact)
» PDF copy of press release (and media contact)

STORY REFERENCES: Thermal Angel Blood Warmer Company Recruits Former Air Force Surgeon General to Sit on Medical Advisory Board, Thermal Angel Blood and IV Fluid Infusion Warmer, Paul K Carlton Jr, advisory board, patented medical device, first responders, triage, US hospitals, military doctor, fluid-induced hypothermia, Jay Lopez, Texas, Institute for Defense and Government Advancement

More Information:

More News From Estill Medical Technologies, Inc.:
Press Release Copr. © Estill Medical Technologies, Inc. (or “news source”) and Send2Press® Newswire. Permission granted for reproduction by news portals, aggregators and news indexes provided original attribution to this site and news source is retained. Cannot be used for commercial purposes/advertising or keyword marketing. All other rights reserved.

This press release has had 1,116 views so far.
http://www.send2press.com/newswire/2010-10-1013-001.shtml
 
DISCLAIMER: the above press release content is believed accurate but not guaranteed, and is based on business news supplied by the "news source." The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press (this Web site) makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope® or the Send2Press® Newswire service. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.